Dr. Mazen Kurban is a Dermatologist and American Board Certified in Clinical Molecular Genetics.
He obtained a degree in dermatology from the American University of Beirut (AUB) Medical Center. He then obtained his Clinical and Molecular Geneticist degree from Columbia University Medical Center, New York.
Dr. Kurban has more than 150 publications in peer-reviewed journals with more than 10 years’ experience of dealing with clinical dermatology patients at AUB.
American University of Beirut
2004American University of Beirut
2008Columbia University, New York, USA
2011Integrative Transcriptome Analyses Empower The Anti-Covid-19 Drug Arsenal. Iscience. 2020, vol.23, no.11, pp-101697.
2020A Novel Traf3ip2 Variant Causing Familial Scarring Alopecia With Mixed Features Of Discoid Lupus Erythematosus And Folliculitis Decalvans. Clinical Genetics. 2020, vol.98, no.2, pp-116-125.
2020Supar, A Potential Inflammatory Mediator In Psoriasis Pathogenesis. Clinical And Experimental Pharmacology & Physiology. 2020.
2020Comparative Characterization Of Sun Exposed And Sun Protected Skin-Derived Mesenchymal-Like Stem Cells In Variegate Porphyria And Healthy Individuals. Photodermatology, Photoimmunology & Photomedicine. 2020.
2020Consanguinity Rates Among Syrian Refugees In Lebanon: A Study On Genetic Awareness. Journal Of Biosocial Science. 2020, pp-1-11.
2020Genodermatoses With Teeth Abnormalities. Oral Diseases. 2020.
2020Loss Of Ferrochelatase Is Protective Against Colon Cancer Cells: Ferrochelatase A Possible Regulator Of The Long Noncoding Rna H19. Journal Of Gastrointestinal Oncology. 2019, vol.10, no.5, pp-859-868.
2019Use Of Topical Glycolic Acid Plus A Lovastatin-Cholesterol Combination Cream For The Treatment Of Autosomal Recessive Congenital Ichthyoses. Jama Dermatology. 2018, vol.154, no.11, pp-1320-1323.
2018Slurp-1 Is Mutated In Mal De Meleda, A Potential Molecular Signature For Melanoma And A Putative Squamous Lineage Tumor Suppressor Gene. International Journal Of Dermatology. 2018, vol.57, no.2, pp-162-170.
2018Erythropoietic Protoporphyria A Clinical And Molecular Study From Lebanon: Ferrochelatase A Potential Tumor Suppressor Gene In Colon Cancer. Clinical Genetics. 2017, vol.92, no.5, pp-495-502.
2017